Discontinued — last reported Q4 '25
IQVIA Contract Sales & Medical Solutions — Business combinations decreased by 100.0% to $0.00 in Q4 2025 compared to the prior quarter. Over 4 years (FY 2021 to FY 2025), Contract Sales & Medical Solutions — Business combinations shows a downward trend with a -6.3% CAGR.
Higher values indicate active M&A activity and integration efforts, which may temporarily impact short-term profitability.
This metric tracks the financial impact of integrating newly acquired entities into the contract sales and medical solut...
Standard for companies pursuing a buy-and-build strategy in the clinical and commercial services market.
iqv_segment_contract_sales_medical_solutions_business_combinations| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $25.00M | $1.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $20.00M | $0.00 |
| QoQ Change | — | — | -96.0% | -100.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -100.0% |
| YoY Change | — | — | — | — | — | -100.0% | -100.0% | — | — | — | — | — | — | — | — | — | — | — | — |